source
- Novo Nordisk CFO describes roller-coaster growth and stays optimistic about CagriSema after Q2 earningsNovo Nordisk CFO Karsten Munk Knudsen talked to Fierce after the company released its second-quarter earnings, reflecting on his nine-year tenure and the firm’s volatile performance. He recalled a…
- Five BioSpace NextGen companies debut on US markets in 2026, four actively hiringBioSpace NextGen honorees accounted for about one third of the 14 U.S. biotech companies that went public in 2026. The five companies together raised roughly $1.5 billion in IPO proceeds, includin…